- Atlas
- Medicine & Health
- Maternal Fetal Medicine
Maternal Fetal Medicine
Maternal-fetal medicine (MFM) is the branch of obstetrics that cares for pregnancies at elevated risk—because of the mother's health, the baby's development, or both—and for the fetus as a patient in its own right.
13 frameworks, from 1950 to today · Obstetrics & Gynecology · Medicine & Health
- Biochemical Placental Function Monitoring 1950-1985
- High-Risk Obstetric Risk Stratification 1950-Present
- Maternal Mortality Audit and Confidential Enquiry 1952-Present
- Obstetric Ultrasound and Prenatal Diagnosis 1960-Present
- Cardiotocography 1965-Present
- Fetal surgery 1965-Present
- Maternal-Fetal Subspecialty Training and Certification 1972-Present
- Antepartum Fetal Surveillance and Biophysical Assessment 1975-Present
- Fetal Therapy 1980-Present
- Population-Based Prenatal Screening 1980-Present
- Evidence-Based Obstetrics 1990-Present
- Risk-Stratified Timed Delivery 2000-Present
- Placental and Angiogenic Biomarker Model of Preeclampsia 2005-Present
Overview
Maternal-fetal medicine (MFM) is the branch of obstetrics that cares for pregnancies at elevated risk—because of the mother's health, the baby's development, or both—and for the fetus as a patient in its own right. Its practitioners are obstetricians with extra training in medical complications of pregnancy, prenatal diagnosis, fetal imaging, and fetal treatment1. What is at stake is the hardest problem in obstetrics: two lives, one physiology, and a margin for error that is often measured in hours. The field's history is the story of how childbirth moved from a largely unmonitored natural event to a process that can be measured, imaged, tested, and sometimes treated before birth—and of the long argument over how much of that technology helps and how much merely intervenes.
From the Lying-In Ward to the High-Risk Clinic
For most of history, obstetrics was general practice: a midwife or doctor attended whatever came. The idea that some pregnancies need special attention emerged in the eighteenth and nineteenth centuries with the lying-in hospitals and the rise of operative obstetrics—forceps, version, and later cesarean section—which concentrated difficult cases in a few hands. The great nineteenth-century advance was not a technique but a hygiene: the recognition, argued most forcefully by Ignaz Semmelweis in Vienna in the 1840s, that puerperal fever was carried from autopsy room to delivery ward on the hands of attendants. Clean hands cut maternal deaths dramatically and established the principle that outcomes depend on the organization of care, not only on the skill of the attendant.
The twentieth century added the tools that would define the specialty. Blood transfusion, antibiotics, and safe anesthesia made cesarean section and major maternal surgery survivable. In Britain, the Confidential Enquiry into Maternal Deaths, begun in 1952, turned every maternal death into a lesson for the system—an early model of audit that shaped how obstetric risk was understood. By mid-century, large hospitals had begun to sort pregnancies into routine and complicated, and the "high-risk" clinic was born.
Seeing the Fetus: Ultrasound and Prenatal Diagnosis
The decisive change was the ability to see and sample the fetus. Ian Donald, an obstetrician in Glasgow, working with engineer Tom Brown and physician John MacVicar, produced the first practical obstetric ultrasound images in the late 1950s, using a contact scanner to distinguish cysts, fibroids, and fetal anatomy. Ultrasound made the fetus visible without radiation, and by the 1970s real-time scanning had become routine: dating pregnancies, locating the placenta, detecting twins and malformations, and guiding needles.
Needle guidance opened the era of prenatal diagnosis. Amniocentesis—sampling amniotic fluid—was developed in the 1960s and 1970s, initially for Rh disease and then for chromosomal analysis; chorionic villus sampling, taking placental tissue earlier in pregnancy, followed in the 1980s. These tests could diagnose Down syndrome and other chromosomal conditions before birth, but they carried a risk of miscarriage, so they were offered mainly to older mothers and families with known risk2. The 1980s and 1990s added maternal serum screening—measuring proteins and hormones in the mother's blood to estimate the chance of chromosomal abnormality—which could be offered to everyone without touching the womb. Later, cell-free fetal DNA testing from a maternal blood sample (non-invasive prenatal testing, introduced around 2011) made screening for common chromosomal conditions far more accurate. The arc of this history is a steady shift from invasive diagnosis for a few to population-wide screening, with the recurring problem of false positives and the counseling burden they create.
Measuring the Fetus: Monitoring and Placental Function
A parallel strand tried to answer a different question: is this fetus well? The 1960s brought electronic fetal monitoring3. Hon and colleagues in New Haven and, independently, Caldeyro-Barcia in Montevideo showed that the fetal heart rate could be recorded continuously and that its patterns—accelerations, decelerations, variability—reflected fetal condition during labor. Continuous monitoring spread rapidly in the 1970s, promising to catch oxygen deprivation before damage occurred. Its history is a cautionary tale: randomized trials later showed that continuous monitoring reduced neonatal seizures but did not reduce cerebral palsy, while increasing cesarean deliveries. The field responded by developing standardized interpretation categories and, in many settings, intermittent auscultation or adjunctive fetal scalp blood sampling to reduce unnecessary intervention.
Before labor, clinicians needed ways to assess the fetus over weeks. Biochemical monitoring of the placenta—measuring estriol, human placental lactogen, and other placental products in maternal blood or urine—was pursued from the 1960s as a way to detect a failing placenta. These tests were largely displaced in the 1980s by the biophysical profile, which combined ultrasound observation of fetal movement, tone, breathing, and amniotic fluid with a non-stress test of heart-rate reactivity. The "fetal surveillance" package—kick counts, non-stress testing, biophysical profile, and Doppler ultrasound of umbilical blood flow—became the standard toolkit for timing delivery in complicated pregnancies.
Preeclampsia: From Seizures to Angiogenic Balance
Preeclampsia—new high blood pressure and protein in the urine after mid-pregnancy—has been the field's central maternal disease. Its old name, toxemia, reflected a belief in a circulating poison. The twentieth century established that the disorder originates in the placenta: abnormal development of the placental blood vessels in early pregnancy leads to a poorly perfused placenta that releases factors injuring the mother's endothelium. Magnesium sulfate, long used to prevent eclamptic seizures, was proven in the Magpie trial (published 2002) to halve the risk of eclampsia—one of the clearest victories of the randomized-trial era in obstetrics.
The most recent conceptual shift is the angiogenic biomarker model. Around the mid-2000s, researchers showed that preeclampsia is marked by an imbalance between placental anti-angiogenic factors—notably soluble fms-like tyrosine kinase-1 (sFlt-1)—and pro-angiogenic factors such as placental growth factor (PlGF). Measuring the sFlt-1/PlGF ratio in maternal blood helps rule in or rule out preeclampsia in women with suspicious symptoms, and has become a clinical tool in many centers. It is a diagnostic aid, not a cure; delivery remains the only definitive treatment.
The Evidence Revolution and Timed Delivery
Obstetrics was long practiced by tradition and authority. The late twentieth century brought the randomized controlled trial and systematic review to the delivery room. The Cochrane Collaboration, founded in 1993, began producing systematic reviews of pregnancy and childbirth interventions, and the term "evidence-based obstetrics" entered the vocabulary. Trials settled questions that had been argued for decades: antenatal corticosteroids for threatened preterm birth (shown by Liggins and Howie in 1972 to reduce neonatal respiratory distress), magnesium sulfate for neuroprotection of the preterm infant, and the choice between planned cesarean and planned vaginal birth in various circumstances.
The most consequential application was risk stratification and timed delivery. The logic is simple: if the intrauterine environment is harming the fetus, delivering earlier may help; but prematurity carries its own costs. Trials such as the Growth Restriction Intervention Trial (GRIT, published 2003) tested whether immediate or delayed delivery was better for growth-restricted fetuses, and the field gradually built algorithms combining gestational age, Doppler findings, and maternal condition to decide when the balance tips. This remains an area of active debate, especially for early-onset growth restriction and for conditions like cholestasis of pregnancy.
Fetal Therapy: Treating the Patient Before Birth
If the fetus can be diagnosed, it can sometimes be treated. Fetal therapy began with transfusion: in the 1960s, A.W. Liley pioneered intrauterine transfusion for severe Rh hemolytic disease, using X-ray guidance to place a needle into the fetal abdomen. Ultrasound later made the procedure safer and allowed direct intravascular transfusion. The 1980s brought open fetal surgery, pioneered by Michael Harrison and colleagues at UCSF, for life-threatening conditions such as congenital diaphragmatic hernia and obstructive uropathy—a dramatic but risky undertaking that required opening the mother's abdomen and uterus.
The most successful fetal intervention is fetoscopic laser coagulation for twin-twin transfusion syndrome, in which abnormal placental connections cause one twin to receive too much blood and the other too little4. The technique, developed in the 1990s, seals the connecting vessels under fetoscopic vision and has become standard care for severe cases. Fetal therapy remains a small, highly specialized field, constrained by the risks to the mother and the difficulty of proving benefit; its history is a series of hard-won, condition-specific victories rather than a general capability.
A Specialty of Its Own
As the knowledge and tools accumulated, so did the need for dedicated training. In the United States, maternal-fetal medicine was recognized as a subspecialty of obstetrics and gynecology, with formal fellowship training and board certification through the American Board of Obstetrics and Gynecology beginning in the 1970s. Similar subspecialty structures developed in the United Kingdom and elsewhere, though the boundaries and titles vary. The creation of the specialty institutionalized the high-risk clinic, the ultrasound unit, and the fetal diagnosis center as distinct parts of the hospital.
The Present: Tools in Tension
Today's maternal-fetal medicine works with a layered toolkit: first-trimester screening and cell-free DNA testing, detailed anatomy scans, Doppler surveillance, angiogenic biomarkers for preeclampsia, antenatal corticosteroids and magnesium for preterm birth, and a small but growing repertoire of fetal interventions. The field's central tension is unresolved. Each new test and monitor can find problems earlier, but earlier detection often leads to intervention whose benefit is uncertain—a dynamic visible in the long decline of continuous fetal monitoring's promise and the persistent debate over when to deliver a growth-restricted fetus. The questions still open are the ones that have driven the field from the start: how to distinguish a fetus in danger from one merely small, how to treat the fetus without harming the mother, and how to make the benefits of specialized care reach everyone who needs it.
References
- Maternal–fetal medicine (introduction, Training), Wikipedia
- Amniocentesis, Wikipedia
- Cardiotocography, Wikipedia
- Twin-to-twin transfusion syndrome, Wikipedia
The frameworks of Maternal Fetal Medicine
Each framework is a way of working the field has used: when it held, and the question it answers.
- 1950-1985
Biochemical Placental Function Monitoring
Is the placenta failing, and can blood tests show it?
- 1950-Present
High-Risk Obstetric Risk Stratification
Which pregnancies need special care and why?
- 1952-Present
Maternal Mortality Audit and Confidential Enquiry
Why do mothers die in childbirth and how can deaths be prevented?
- 1960-Present
Obstetric Ultrasound and Prenatal Diagnosis
What can we see and sample in the unborn baby?
- 1965-Present
Cardiotocography
Is the baby's heart rate showing distress during labor?
- 1965-Present
- 1972-Present
Maternal-Fetal Subspecialty Training and Certification
Who should be trained to care for complicated pregnancies?
- 1975-Present
Antepartum Fetal Surveillance and Biophysical Assessment
Is this fetus well enough to wait, or must it be delivered?
- 1980-Present
- 1980-Present
Population-Based Prenatal Screening
How can we estimate every pregnancy's chance of abnormality?
- 1990-Present
Evidence-Based Obstetrics
Which obstetric practices actually help, as shown by trials?
- 2000-Present
Risk-Stratified Timed Delivery
When is the right moment to deliver a compromised fetus?
- 2005-Present
Placental and Angiogenic Biomarker Model of Preeclampsia
Can blood markers diagnose preeclampsia before it becomes dangerous?
How the ideas connect
Each arrow runs from an earlier idea to the later one it shaped. The list below says what passed between them.
Antepartum Fetal Surveillance and Biophysical Assessment replaced Biochemical Placental Function Monitoring
Biochemical placental function tests such as estriol and human placental lactogen were displaced in the late 1970s and 1980s by the biophysical profile and non-stress testing, which assessed the fetus directly by ultrasound and heart-rate reactivity rather than through placental products in maternal blood.
Carried by Frank Manning.
Risk-Stratified Timed Delivery grew out of High-Risk Obstetric Risk Stratification
Risk-stratified timed delivery grew directly out of high-risk obstetric risk stratification: once pregnancies were sorted by risk, the next step was to use gestational age, Doppler findings and maternal condition to decide when delivery tips the balance.
Carried by Growth Restriction Intervention Trial (2003).
Fetal surgery influenced by Obstetric Ultrasound and Prenatal Diagnosis
Obstetric ultrasound made the fetus visible and allowed needles to be guided into the womb, which was the technical precondition for open fetal surgery and for safer intrauterine transfusion.
Carried by Michael Harrison.
Antepartum Fetal Surveillance and Biophysical Assessment influenced by Obstetric Ultrasound and Prenatal Diagnosis
The biophysical profile was built on real-time ultrasound observation of fetal movement, tone, breathing and amniotic fluid, so antepartum surveillance depended directly on obstetric ultrasound.
Carried by Frank Manning.
Fetal Therapy grew out of Fetal surgery
Fetal therapy grew out of the first fetal surgery and transfusion work: open fetal surgery for life-threatening conditions was the direct ancestor of the broader fetal therapy enterprise, including fetoscopic laser for twin-twin transfusion syndrome.
Carried by Michael Harrison.
Evidence-Based Obstetrics influenced by Maternal Mortality Audit and Confidential Enquiry
The Confidential Enquiry into Maternal Deaths supplied obstetrics with an early model of systematic audit, and the evidence-based obstetrics movement took up that audit logic and extended it to systematic review of interventions.
Carried by Confidential Enquiry into Maternal Deaths.
Population-Based Prenatal Screening influenced by Obstetric Ultrasound and Prenatal Diagnosis
Ultrasound dating and anomaly detection, together with ultrasound-guided amniocentesis and chorionic villus sampling, established the diagnostic targets that population-based serum and later cell-free DNA screening were designed to estimate risk for.
Antepartum Fetal Surveillance and Biophysical Assessment influenced by Cardiotocography
The non-stress test component of antepartum surveillance came from electronic fetal heart-rate recording developed for labor, applied before labor to test heart-rate reactivity.
Risk-Stratified Timed Delivery influenced by Antepartum Fetal Surveillance and Biophysical Assessment
Antepartum surveillance tools, especially Doppler and biophysical assessment, supplied the measurements that risk-stratified timed-delivery algorithms use to decide when to deliver a compromised fetus.
Carried by Growth Restriction Intervention Trial (2003).
Placental and Angiogenic Biomarker Model of Preeclampsia revived Biochemical Placental Function Monitoring
The idea that measuring placental products in maternal blood can report on placental health returned in the angiogenic biomarker model, where the sFlt-1/PlGF ratio is read as a marker of placental dysfunction in preeclampsia.
Placental and Angiogenic Biomarker Model of Preeclampsia influenced by Population-Based Prenatal Screening
Population-based prenatal screening established the practice of measuring maternal blood markers to estimate obstetric risk, a model the angiogenic biomarker approach extended to preeclampsia with the sFlt-1/PlGF ratio.
Beyond the field
Where Maternal Fetal Medicine's ideas came from in other fields, and what they led to there: the strongest 12 of 42 links.
High-Risk Obstetric Risk Stratification influenced by Medical Model of Obstetric Risk Management in Obstetrics
Formal high-risk obstetric risk stratification extended the medical model of obstetric risk management, which had already framed pregnancy as a condition requiring medical surveillance and intervention; mid-century scoring systems applied that framework systematically across populations.
High-Risk Obstetric Risk Stratification led to Fetal Surveillance and Maternal-Fetal Medicine in Obstetrics
High-risk obstetric risk stratification is the organising framework on which maternal-fetal medicine was built: identifying pregnancies at risk and directing surveillance and specialist care at them. The specialty's whole remit is the intensive management of the pregnancies so identified.
Maternal Mortality Audit and Confidential Enquiry influenced by Civil Registration and Vital Statistics in Global Health Metrics And Evaluation
Maternal mortality audit depends on civil registration of births and deaths with cause of death; the confidential enquiry into maternal deaths in England and Wales was built by linking death certificates to birth records through the national registration system.
Maternal Mortality Audit and Confidential Enquiry led to Safe Motherhood and Emergency Obstetric Care in Obstetrics
The Safe Motherhood Initiative's strategy of measuring and reducing maternal deaths grew directly out of the confidential enquiry system established in Britain in 1952, which provided the audit method and the evidence of avoidable deaths it sought to export to developing countries. The 1987 Nairobi conference built on that model.
Carried by Confidential Enquiry into Maternal Deaths (1952).
Cardiotocography influenced by Electrocardiography in Cardiology
Cardiotocography applied electrocardiographic recording principles to the fetal heart, using the ECG concepts of rate and rhythm and adapting electrodes and amplifiers developed for adult electrocardiography to record the fetal heart rate.
Fetal Therapy grew out of Maternal-fetal medicine in Obstetrics & Gynecology
Fetal therapy emerged as a branch of maternal-fetal medicine: the subspecialty's fetal diagnostic and monitoring capabilities, together with its practitioners, produced the first fetal surgical and transfusion interventions in the early 1980s.
Carried by Michael Harrison.
Population-Based Prenatal Screening influenced by Predictive and Prenatal Testing in Medical Genetics
Predictive and prenatal testing in medical genetics, including amniocentesis and biochemical marker assays, provided the tests and risk-calculation concepts that population-based prenatal screening programs adopted.
Evidence-Based Obstetrics influenced by Randomized Controlled Trial and Evidence-Based Medicine in History Of Medicine
The randomized controlled trial and the evidence-based medicine movement supplied the hierarchy of evidence and trial methodology that evidence-based obstetrics applied to perinatal care.
Evidence-Based Obstetrics influenced by Systematic Review and Meta-analysis in Evidence Based Medicine
Systematic review and meta-analysis methods, developed from the 1970s by Cochrane and others, were adopted by obstetricians to synthesize trial evidence, notably in the Cochrane Pregnancy and Childbirth Database, forming the methodological core of evidence-based obstetrics.
Carried by Archie Cochrane; Iain Chalmers.
Risk-Stratified Timed Delivery grew out of Medical Model of Obstetric Risk Management in Obstetrics
Risk-stratified timed delivery is a refinement of the medical model of obstetric risk management: it takes the older model's risk categories and adds explicit timing rules for delivery based on risk level.
Placental and Angiogenic Biomarker Model of Preeclampsia grew out of Maternal-fetal medicine in Obstetrics & Gynecology
The placental and angiogenic biomarker model is a research program within maternal-fetal medicine, developed by investigators in that specialty who applied its clinical cohorts and biobanking to preeclampsia. It is a branch of the field rather than an independent tradition.
Biochemical Placental Function Monitoring influenced by Hormonal Regulation and Homeostasis in Metabolic Nutrition
Assays of placental hormones such as human chorionic gonadotropin and estriol for monitoring pregnancy drew directly on the endocrine concept of hormonal regulation and feedback homeostasis established by the steroid and protein hormone biochemistry of the 1920s-30s.

Maternal Fetal Medicine is a planet in Nousfarer
Its city has a tower for each of these 13 frameworks. Land, walk in, and climb one concept at a time.
Land on Maternal Fetal MedicineRelated fields
Fields its ideas are linked to
- Obstetrics 13 links
- Obstetrics & Gynecology 9 links
- Neonatology 3 links
- Reproductive Physiology 2 links
- Medical Genetics 2 links
- Global Health Metrics And Evaluation 2 links
- Midwifery 2 links
- Biomedical Signal Processing 1 link
- Critical Care Medicine 1 link
- History Of Medicine 1 link
- Cardiology 1 link
- Evidence Based Medicine 1 link
More in Obstetrics & Gynecology
- Contraception And Family Planning
- General Gynecology
- Gynecologic Oncology
- Midwifery
- Obstetrics
- Obstetrics & Gynecology
- Reproductive Medicine
See where Maternal Fetal Medicine sits on the Map of Human Knowledge